---
title: "Roche: Projects directly targeting patients focus on same-day delivery services in certain markets i"
description: "Roche: Projects directly targeting patients focus on same-day delivery services in certain markets in the United States, enhancing the payment capabilities of underinsured, uninsured, or self-paying p"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/261480597.md"
published_at: "2025-10-16T15:47:10.000Z"
---

# Roche: Projects directly targeting patients focus on same-day delivery services in certain markets i

> Roche: Projects directly targeting patients focus on same-day delivery services in certain markets in the United States, enhancing the payment capabilities of underinsured, uninsured, or self-paying patients

Roche: Projects directly targeting patients focus on same-day delivery services in certain markets in the United States, enhancing the payment capabilities of underinsured, uninsured, or self-paying patients

### Related Stocks

- [RHHBY.US - Roche](https://longbridge.com/en/quote/RHHBY.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| 惠誉在更新公司评级标准后维持了对 Hikma 和罗氏的评级 | 惠誉在更新企业评级标准后维持对 Hikma 和罗氏 (ADR) 的评级 | [Link](https://longbridge.com/en/news/275874477.md) |
| 罗氏公司任命马克·道森为罗氏制药研究与早期开发部门的新负责人 | 罗氏控股公司：罗氏控股公司 - 任命马克·道森（Mark Dawson），医学博士，哲学博士，担任罗氏制药研究与早期开发（PRED）新负责人，任命自 2026 年 5 月 1 日起生效 | [Link](https://longbridge.com/en/news/276097246.md) |
| 罗氏的 Gazyva 在晚期肾病研究中达成了主要目标 | 罗氏的 Gazyva 在晚期肾病研究中达成主要目标 | [Link](https://longbridge.com/en/news/276037536.md) |
| 罗氏报告 2025 财年归属净收入和销售额增长 | 罗氏报告 FY25 可归属净收入和销售额增长 | [Link](https://longbridge.com/en/news/274100655.md) |
| 基因泰克报告 Gazyva 在原发性膜性肾病中的 III 期试验结果呈现积极效果 | 基因泰克（Genentech），罗氏集团的一部分，宣布了 Gazyva 在治疗原发性膜性肾病的 III 期临床试验的积极结果。MAJESTY 研究达到了其主要终点，显示 Gazyva 与他克莫司相比具有显著的益处，包括两年内完全缓解的更高比 | [Link](https://longbridge.com/en/news/276037337.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.